{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T14:21:34Z","timestamp":1788531694326,"version":"build-2803163510"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T00:00:00Z","timestamp":1788480000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T00:00:00Z","timestamp":1788480000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100015377","name":"Nihon Medi-Physics","doi-asserted-by":"publisher","award":["Nihon Medi-Physics"],"award-info":[{"award-number":["Nihon Medi-Physics"]}],"id":[{"id":"10.13039\/100015377","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Nucl Med"],"DOI":"10.1007\/s12149-026-02281-2","type":"journal-article","created":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T13:42:08Z","timestamp":1788529328000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Association of global gray matter volume and cortical thickness with cognitive function stratified by amyloid PET status"],"prefix":"10.1007","author":[{"given":"Yujiro","family":"Nakaoka","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koji","family":"Sohara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Matsuda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sunao","family":"Mizumura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaya","family":"Suda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shogo","family":"Imai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tetsuro","family":"Sekine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahiro","family":"Ando","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aruki","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akiko","family":"Ishiwata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amane","family":"Tateno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michihiko","family":"Koeda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomonari","family":"Saito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoshi","family":"Suda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akiko","family":"Yamazaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiromitsu","family":"Hayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinichiro","family":"Kumita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,4]]},"reference":[{"issue":"8","key":"2281_CR1","doi-asserted-by":"publisher","first-page":"5143","DOI":"10.1002\/alz.13859","volume":"20","author":"CR Jack Jr","year":"2024","unstructured":"Jack CR Jr, Andrews JS, Beach TG, Buracchio T, Dunn B, Graf A, et al. Revised criteria for diagnosis and staging of Alzheimer\u2019s disease: Alzheimer\u2019s Association Workgroup. Alzheimers Dement. 2024;20(8):5143\u201369.","journal-title":"Alzheimers Dement"},{"issue":"7","key":"2281_CR2","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1001\/jamaneurol.2025.1100","volume":"82","author":"A Pichet Binette","year":"2025","unstructured":"Pichet Binette A, Smith R, Salvad\u00f3 G, Tideman P, Glans I, van Westen D, et al. Evaluation of the revised criteria for biological and clinical staging of Alzheimer disease. JAMA Neurol. 2025;82(7):666\u201375.","journal-title":"JAMA Neurol"},{"issue":"2","key":"2281_CR3","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1038\/nrneurol.2009.215","volume":"6","author":"GB Frisoni","year":"2010","unstructured":"Frisoni GB, Fox NC, Jack CR Jr, Scheltens P, Thompson PM. The clinical use of structural MRI in Alzheimer disease. Nat Rev Neurol. 2010;6(2):67\u201377.","journal-title":"Nat Rev Neurol"},{"issue":"Pt 8","key":"2281_CR4","doi-asserted-by":"publisher","first-page":"2048","DOI":"10.1093\/brain\/awp123","volume":"132","author":"RS Desikan","year":"2009","unstructured":"Desikan RS, Cabral HJ, Hess CP, Dillon WP, Glastonbury CM, Weiner MW, et al. Automated MRI measures identify individuals with mild cognitive impairment and Alzheimer\u2019s disease. Brain. 2009;132(Pt 8):2048\u201357.","journal-title":"Brain"},{"issue":"Pt 8","key":"2281_CR5","doi-asserted-by":"publisher","first-page":"2036","DOI":"10.1093\/brain\/awp105","volume":"132","author":"O Querbes","year":"2009","unstructured":"Querbes O, Aubry F, Pariente J, Lotterie JA, D\u00e9monet JF, Duret V, et al. Early diagnosis of Alzheimer\u2019s disease using cortical thickness: impact of cognitive reserve. Brain. 2009;132(Pt 8):2036\u201347.","journal-title":"Brain"},{"issue":"5","key":"2281_CR6","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1159\/000256274","volume":"28","author":"V Julkunen","year":"2009","unstructured":"Julkunen V, Niskanen E, Muehlboeck S, Pihlajam\u00e4ki M, K\u00f6n\u00f6nen M, Hallikainen M, et al. Cortical thickness analysis to detect progressive mild cognitive impairment: a reference to Alzheimer\u2019s disease. Dement Geriatr Cogn Disord. 2009;28(5):404\u201312.","journal-title":"Dement Geriatr Cogn Disord"},{"issue":"2","key":"2281_CR7","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1212\/WNL.0b013e31823efc6c","volume":"78","author":"BC Dickerson","year":"2012","unstructured":"Dickerson BC, Wolk DA. MRI cortical thickness biomarker predicts AD-like CSF and cognitive decline in normal adults. Neurology. 2012;78(2):84\u201390.","journal-title":"Neurology"},{"issue":"4","key":"2281_CR8","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1007\/BF02988523","volume":"17","author":"S Mizumura","year":"2003","unstructured":"Mizumura S, Kumita S, Cho K, Ishihara M, Nakajo H, Toba M, et al. Development of quantitative analysis method for stereotactic brain image: assessment of reduced accumulation in extent and severity using anatomical segmentation. Ann Nucl Med. 2003;17(4):289\u201395.","journal-title":"Ann Nucl Med"},{"issue":"1","key":"2281_CR9","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1007\/BF02985609","volume":"18","author":"S Mizumura","year":"2004","unstructured":"Mizumura S, Nakagawara J, Takahashi M, Kumita S, Cho K, Nakajo H, et al. Three-dimensional display in staging hemodynamic brain ischemia for JET study: objective evaluation using SEE analysis and 3D-SSP display. Ann Nucl Med. 2004;18(1):13\u201321.","journal-title":"Ann Nucl Med"},{"issue":"4","key":"2281_CR10","first-page":"731","volume":"28","author":"H Matsuda","year":"2007","unstructured":"Matsuda H, Mizumura S, Nagao T, Ota T, Iizuka T, Nemoto K, et al. Automated discrimination between very early Alzheimer disease and controls using an easy Z-score imaging system for multicenter brain perfusion single-photon emission tomography. AJNR Am J Neuroradiol. 2007;28(4):731\u20136.","journal-title":"AJNR Am J Neuroradiol"},{"issue":"7","key":"2281_CR11","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1007\/s12149-020-01477-4","volume":"34","author":"K Sohara","year":"2020","unstructured":"Sohara K, Kiriyama T, Mizumura S, Ishiwata A, Yamazaki M, Kimura K, et al. Diagnostic utility and characteristics of CT-based attenuation correction in brain perfusion SPECT\/CT in predicting the exacerbation of Alzheimer changes from mild cognitive impairment utilizing voxel-based statistical analysis in comparison with Chang\u2019s method. Ann Nucl Med. 2020;34(7):502\u201311.","journal-title":"Ann Nucl Med"},{"issue":"7","key":"2281_CR12","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1007\/s11604-006-0056-8","volume":"24","author":"S Mizumura","year":"2006","unstructured":"Mizumura S, Kumita S. Stereotactic statistical imaging analysis of the brain using the easy Z-score imaging system for sharing a normal database. Radiat Med. 2006;24(7):545\u201352.","journal-title":"Radiat Med"},{"issue":"6","key":"2281_CR13","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.3174\/ajnr.A2935","volume":"33","author":"H Matsuda","year":"2012","unstructured":"Matsuda H, Mizumura S, Nemoto K, Yamashita F, Imabayashi E, Sato N, et al. Automatic voxel-based morphometry of structural MRI by SPM8 plus diffeomorphic anatomic registration through exponentiated lie algebra improves the diagnosis of probable Alzheimer disease. AJNR Am J Neuroradiol. 2012;33(6):1109\u201314.","journal-title":"AJNR Am J Neuroradiol"},{"issue":"1","key":"2281_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jalz.2014.07.003","volume":"11","author":"WE Klunk","year":"2015","unstructured":"Klunk WE, Koeppe RA, Price JC, Benzinger TL, Devous MD, Sr, Jagust WJ, et al. The Centiloid Project: standardizing quantitative amyloid plaque estimation by PET. Alzheimers Dement. 2015;11(1):1\u2013e151.","journal-title":"Alzheimers Dement"},{"issue":"12","key":"2281_CR15","doi-asserted-by":"publisher","first-page":"9037","DOI":"10.1002\/alz.14336","volume":"20","author":"LE Collij","year":"2024","unstructured":"Collij LE, Bollack A, La Joie R, Shekari M, Bullich S, Ro\u00e9-Vellv\u00e9 N, et al. Centiloid recommendations for clinical context-of-use from the AMYPAD consortium. Alzheimers Dement. 2024;20(12):9037\u201348.","journal-title":"Alzheimers Dement"},{"issue":"3","key":"2281_CR16","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1002\/ana.22068","volume":"68","author":"R Vandenberghe","year":"2010","unstructured":"Vandenberghe R, Van Laere K, Ivanoiu A, Salmon E, Bastin C, Triau E, et al. 18F-flutemetamol amyloid imaging in Alzheimer disease and mild cognitive impairment: a phase 2 trial. Ann Neurol. 2010;68(3):319\u201329.","journal-title":"Ann Neurol"},{"issue":"8","key":"2281_CR17","doi-asserted-by":"publisher","first-page":"1316","DOI":"10.2967\/jnumed.116.174615","volume":"57","author":"S Minoshima","year":"2016","unstructured":"Minoshima S, Drzezga AE, Barthel H, Bohnen N, Djekidel M, Lewis DH, et al. SNMMI Procedure Standard\/EANM Practice Guideline for Amyloid PET Imaging of the Brain 1.0. J Nucl Med. 2016;57(8):1316\u201322.","journal-title":"J Nucl Med"},{"key":"2281_CR18","doi-asserted-by":"publisher","first-page":"578753","DOI":"10.3389\/fneur.2020.578753","volume":"11","author":"H Matsuda","year":"2021","unstructured":"Matsuda H, Ito K, Ishii K, Shimosegawa E, Okazawa H, Mishina M, et al. Quantitative evaluation of 18F-flutemetamol PET in patients with cognitive impairment and suspected Alzheimer\u2019s disease: a multicenter study. Front Neurol. 2021;11:578753.","journal-title":"Front Neurol"},{"issue":"12","key":"2281_CR19","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1007\/s12149-022-01792-y","volume":"36","author":"H Matsuda","year":"2022","unstructured":"Matsuda H, Okita K, Motoi Y, Mizuno T, Ikeda M, Sanjo N, et al. Clinical impact of amyloid PET using 18F-florbetapir in patients with cognitive impairment and suspected Alzheimer\u2019s disease: a multicenter study. Ann Nucl Med. 2022;36(12):1039\u201349.","journal-title":"Ann Nucl Med"},{"issue":"3","key":"2281_CR20","doi-asserted-by":"publisher","first-page":"e2499","DOI":"10.1002\/brb3.2499","volume":"12","author":"H Matsuda","year":"2022","unstructured":"Matsuda H, Yamao T. Software development for quantitative analysis of brain amyloid PET. Brain Behav. 2022;12(3):e2499.","journal-title":"Brain Behav"},{"issue":"6","key":"2281_CR21","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1007\/s12149-024-01919-3","volume":"38","author":"C Shang","year":"2024","unstructured":"Shang C, Sakurai K, Nihashi T, Arahata Y, Takeda A, Ishii K, et al. Comparison of consistency in centiloid scale among different analytical methods in amyloid PET: the CapAIBL, VIZCalc, and Amyquant methods. Ann Nucl Med. 2024;38(6):460\u20137.","journal-title":"Ann Nucl Med"},{"issue":"7","key":"2281_CR22","doi-asserted-by":"publisher","first-page":"2183","DOI":"10.1007\/s00259-021-05311-5","volume":"48","author":"M Bucci","year":"2021","unstructured":"Bucci M, Savitcheva I, Farrar G, Salvad\u00f3 G, Collij LE, Dor\u00e9 V, et al. A multisite analysis of the concordance between visual image interpretation and quantitative analysis of [18F]flutemetamol amyloid PET images. Eur J Nucl Med Mol Imaging. 2021;48(7):2183\u201399.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"7","key":"2281_CR23","doi-asserted-by":"publisher","first-page":"2169","DOI":"10.1007\/s00259-020-05174-2","volume":"48","author":"LE Collij","year":"2021","unstructured":"Collij LE, Salvad\u00f3 G, Shekari M, Lopes Alves I, Reimand J, Wink AM, et al. Visual assessment of [18F]flutemetamol PET images can detect early amyloid pathology and grade its extent. Eur J Nucl Med Mol Imaging. 2021;48(7):2169\u201382.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"1","key":"2281_CR24","doi-asserted-by":"publisher","first-page":"493","DOI":"10.21037\/qims-21-188","volume":"12","author":"EG M\u00fcller","year":"2022","unstructured":"M\u00fcller EG, Stokke C, Stokmo HL, Edwin TH, Knapskog AB, Revheim ME. Evaluation of semi-quantitative measures of 18F-flutemetamol PET for the clinical diagnosis of Alzheimer\u2019s disease. Quant Imaging Med Surg. 2022;12(1):493\u2013509.","journal-title":"Quant Imaging Med Surg"},{"issue":"10","key":"2281_CR25","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1007\/s12149-022-01769-x","volume":"36","author":"E Imabayashi","year":"2022","unstructured":"Imabayashi E, Tamamura N, Yamaguchi Y, Kamitaka Y, Sakata M, Ishii K. Automated semi-quantitative amyloid PET analysis technique without MR images for Alzheimer\u2019s disease. Ann Nucl Med. 2022;36(10):865\u201375.","journal-title":"Ann Nucl Med"},{"issue":"10","key":"2281_CR26","doi-asserted-by":"publisher","first-page":"3508","DOI":"10.1007\/s00259-022-05784-y","volume":"49","author":"HG Pemberton","year":"2022","unstructured":"Pemberton HG, Collij LE, Heeman F, Bollack A, Shekari M, Salvad\u00f3 G, et al. Quantification of amyloid PET for future clinical use: a state-of-the-art review. Eur J Nucl Med Mol Imaging. 2022;49(10):3508\u201328.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"1","key":"2281_CR27","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/s13550-023-00994-3","volume":"13","author":"HG Pemberton","year":"2023","unstructured":"Pemberton HG, Buckley C, Battle M, Bollack A, Patel V, Tomova P, et al. Software compatibility analysis for quantitative measures of [18F]flutemetamol amyloid PET burden in mild cognitive impairment. EJNMMI Res. 2023;13(1):48.","journal-title":"EJNMMI Res"},{"key":"2281_CR28","doi-asserted-by":"publisher","DOI":"10.1186\/s40658-026-00930-z","author":"K Sohara","year":"2026","unstructured":"Sohara K, Matsuda H, Mizumura S, Nakaoka Y, Imai S, Suda M, et al. Calibrated bridging of 60- and 90-min [18F]flutemetamol PET on digital SiPM PET\/CT: a within-subject agreement study. EJNMMI Phys. 2026. https:\/\/doi.org\/10.1186\/s40658-026-00930-z","journal-title":"EJNMMI Phys"},{"issue":"2","key":"2281_CR29","doi-asserted-by":"publisher","first-page":"205","DOI":"10.4306\/pi.2017.14.2.205","volume":"14","author":"EH Seo","year":"2017","unstructured":"Seo EH, Park WY, Choo IH. Structural MRI and amyloid PET imaging for prediction of conversion to Alzheimer\u2019s disease in patients with mild cognitive impairment: a meta-analysis. Psychiatry Investig. 2017;14(2):205\u201315.","journal-title":"Psychiatry Investig"},{"issue":"1","key":"2281_CR30","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1186\/s12883-019-1498-9","volume":"19","author":"M Ortner","year":"2019","unstructured":"Ortner M, Drost R, Hedderich D, Goldhardt O, M\u00fcller-Sarnowski F, Diehl-Schmid J, et al. Amyloid PET, FDG-PET or MRI? - the power of different imaging biomarkers to detect progression of early Alzheimer\u2019s disease. BMC Neurol. 2019;19(1):264.","journal-title":"BMC Neurol"},{"issue":"5","key":"2281_CR31","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1002\/gps.4173","volume":"30","author":"A Tateno","year":"2015","unstructured":"Tateno A, Sakayori T, Kawashima Y, Higuchi M, Suhara T, Mizumura S, et al. Comparison of imaging biomarkers for Alzheimer\u2019s disease: amyloid imaging with [18F]florbetapir positron emission tomography and magnetic resonance imaging voxel-based analysis for entorhinal cortex atrophy. Int J Geriatr Psychiatry. 2015;30(5):505\u201313.","journal-title":"Int J Geriatr Psychiatry"},{"issue":"7","key":"2281_CR32","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1007\/s12149-025-02046-3","volume":"39","author":"S Takemoto","year":"2025","unstructured":"Takemoto S, Onuki K, Tanimoto K, Taniguchi M, Suero T, Okamoto M, et al. Elapsed time changes of the brain radiopharmaceutical accumulation of the amyloid PET examination using 18F-flutemetamol. Ann Nucl Med. 2025;39(7):732\u201346.","journal-title":"Ann Nucl Med"},{"key":"2281_CR33","doi-asserted-by":"publisher","first-page":"giae049","DOI":"10.1093\/gigascience\/giae049","volume":"13","author":"C Gaser","year":"2024","unstructured":"Gaser C, Dahnke R, Thompson PM, Kurth F, Luders E. Alzheimer\u2019s Disease Neuroimaging Initiative. CAT: a computational anatomy toolbox for the analysis of structural MRI data. Gigascience. 2024;13:giae049.","journal-title":"Gigascience"},{"key":"2281_CR34","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1016\/j.neuroimage.2012.09.050","volume":"65","author":"R Dahnke","year":"2013","unstructured":"Dahnke R, Yotter RA, Gaser C. Cortical thickness and central surface estimation. NeuroImage. 2013;65:336\u201348.","journal-title":"NeuroImage"},{"issue":"3","key":"2281_CR35","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/0022-3956(75)90026-6","volume":"12","author":"MF Folstein","year":"1975","unstructured":"Folstein MF, Folstein SE, McHugh PR. Mini-mental state. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975;12(3):189\u201398.","journal-title":"J Psychiatr Res"},{"issue":"8","key":"2281_CR36","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.2967\/jnumed.106.037218","volume":"48","author":"H Matsuda","year":"2007","unstructured":"Matsuda H. Role of neuroimaging in Alzheimer\u2019s disease, with emphasis on brain perfusion SPECT. J Nucl Med. 2007;48(8):1289\u2013300.","journal-title":"J Nucl Med"},{"issue":"1","key":"2281_CR37","doi-asserted-by":"publisher","first-page":"24","DOI":"10.3174\/ajnr.A8469","volume":"46","author":"PM Cogswell","year":"2025","unstructured":"Cogswell PM, Andrews TJ, Barakos JA, Barkhof F, Bash S, Benayoun MD, et al. Alzheimer disease anti-amyloid immunotherapies: imaging recommendations and practice considerations for monitoring of amyloid-related imaging abnormalities. AJNR Am J Neuroradiol. 2025;46(1):24\u201332.","journal-title":"AJNR Am J Neuroradiol"},{"issue":"1","key":"2281_CR38","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1186\/s13195-023-01351-1","volume":"15","author":"LE Collij","year":"2023","unstructured":"Collij LE, Farrar G, Reimand J, Lopes Alves I, Vilanova M, Bischof GN, et al. Clinical outcomes up to 9 years after [18F]flutemetamol amyloid-PET in a symptomatic memory clinic population. Alzheimers Res Ther. 2023;15(1):207.","journal-title":"Alzheimers Res Ther"},{"issue":"5","key":"2281_CR39","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1007\/s12149-025-02018-7","volume":"39","author":"H Matsuda","year":"2025","unstructured":"Matsuda H, Hanyu H, Kaneko C, Ogura M, Yamao T. Highly specific amyloid and tau PET ligands for ATN classification in suspected Alzheimer\u2019s disease patients. Ann Nucl Med. 2025;39(5):458\u201365.","journal-title":"Ann Nucl Med"},{"issue":"1","key":"2281_CR40","doi-asserted-by":"publisher","first-page":"6635","DOI":"10.1038\/s41467-022-34129-4","volume":"13","author":"A Pichet Binette","year":"2022","unstructured":"Pichet Binette A, Franzmeier N, Spotorno N, Ewers M, Brendel M, Biel D, et al. Amyloid-associated increases in soluble tau relate to tau aggregation rates and cognitive decline in early Alzheimer\u2019s disease. Nat Commun. 2022;13(1):6635.","journal-title":"Nat Commun"}],"container-title":["Annals of Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12149-026-02281-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12149-026-02281-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12149-026-02281-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T13:42:10Z","timestamp":1788529330000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12149-026-02281-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,4]]},"references-count":40,"alternative-id":["2281"],"URL":"https:\/\/doi.org\/10.1007\/s12149-026-02281-2","relation":{},"ISSN":["0914-7187","1864-6433"],"issn-type":[{"value":"0914-7187","type":"print"},{"value":"1864-6433","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,4]]},"assertion":[{"value":"8 July 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no personal competing interests. Nippon Medical School received commissioned research funding from Nihon Medi-Physics Co., Ltd. for this investigator-initiated study.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study protocol was approved by the Central Ethics Committee of the Nippon Medical School Foundation (approval no. M-2025-428) and was conducted in accordance with the Declaration of Helsinki.","order":2,"name":"Ethics","label":"Ethics approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The requirement for written informed consent was waived by the ethics committee, and study information was disclosed using an opt-out procedure.","order":3,"name":"Ethics","label":"Consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}}]}}